KLOW is a co-lyophilised research-peptide blend supplied as a sterile lyophilised powder for in-vitro laboratory investigation of the receptor-binding properties of each component. Components: GHK-Cu (copper-binding tripeptide), KPV (tripeptide fragment of α-MSH), Larazotide (octapeptide), and Orexin-A (33-amino-acid neuropeptide). Each batch is characterised by reversed-phase HPLC (≥99%, each component) and identity-confirmed by mass spectrometry; a per-batch Certificate of Analysis is issued with every shipment. Specifications Purity: ≥99% (RP-HPLC, each component) Identity: MS-verified Form: Lyophilised powder, sealed vial Storage: −20 °C, protected from light Manufacturer: Oxford Research Syndicate Ltd Batch / Lot: supplied on COA For in-vitro laboratory research use only. Not a medicinal product. Not for human, veterinary, diagnostic, therapeutic or in-vivo use. Not for resale to the general public.